EmeraMed's Unattributed - II Round

EmeraMed raised a round of funding on February 29, 2016.

EmeraMed, formerly Ermes Medical Company, is a biotechnology firm developing metal chelator and anti oxidant NBMI (Irminix). The Company is working to obtain marketing authorization in the EU and the …

Articles about EmeraMed's Unattributed - II Round: